The heart inside a skeleton

Nyrada pushes through to third cohort in Phase 1 trial for NYR-BI03

Nyrada Inc has been given the go-ahead to a third cohort in its Phase 1 clinical…
Medical imaging of the human heart

Monash tests show strong cardioprotective qualities for Algorae drug candidate

Algorae Pharmaceutical Ltd has completed preclinical tests on its drug candidate for heart disease, AI-168